Phase 2 results of lisocabtagene maraleucel in Japanese patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
lisocabtagene maraleucel 治疗日本复发/难治性侵袭性 B 细胞非霍奇金淋巴瘤患者的第 2 阶段结果
期刊:Cancer Medicine
影响因子:2.9
doi:10.1002/cam4.4820
Shinichi Makita, Go Yamamoto, Dai Maruyama, Yuki Asano-Mori, Daisuke Kaji, Revathi Ananthakrishnan, Ken Ogasawara, Lara Stepan, Claudia Schusterbauer, Nils Rettby, Jens Hasskarl, Koji Izutsu
